{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:35:15Z","timestamp":1707525315307},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,10]]},"DOI":"10.7759\/cureus.46784","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T11:52:35Z","timestamp":1696938755000},"source":"Crossref","is-referenced-by-count":0,"title":["Thrombotic Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccination in a Patient With Multiple Myeloma: Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Chitramalya","family":"Dan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshat","family":"Sahai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepmalya","family":"Dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anmol","family":"Sahai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram","family":"Trehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"COMIRNATY\u00ae (COVID-19 Vaccine, mRNA) suspension for injection, for intramuscular use 2023-2024 Formula, Prescribing Information, Pfizer and BioNTech. (2023). Accessed. September 11, 2023: https:\/\/www.cvdvaccine-us.com\/12-up-yearsold\/overview\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.36518\/2689-0216.1384","article-title":"Acute thrombotic thrombocytopenic purpura: rare and life-threatening side effect of recent BNT-162b2 COVID-19 vaccination","volume":"3","author":"Patel J","year":"2022","unstructured":"Patel J, Jahngir MU, Abdulzahir A, Rodriguez I. Acute thrombotic thrombocytopenic purpura: rare and life-threatening side effect of recent BNT-162b2 COVID-19 vaccination. HCA Healthc J Med. 2022, 3:343-8. 10.36518\/2689-0216.1384","journal-title":"HCA Healthc J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.55729\/2000-9666.1073","article-title":"Recurrence of thrombotic thrombocytopenic purpura after vaccination with mRNA-1273 COVID-19 vaccine","volume":"12","author":"Ntelis S","year":"2022","unstructured":"Ntelis S, Champ K. Recurrence of thrombotic thrombocytopenic purpura after vaccination with mRNA-1273 COVID-19 vaccine. J Community Hosp Intern Med Perspect. 2022, 12:80-4. 10.55729\/2000-9666.1073","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2023.e01795","article-title":"Thrombotic thrombocytopenic purpura following ChAdOx1 nCov-19 vaccination: A case report","volume":"32","author":"Shateri Amiri B","year":"2023","unstructured":"Shateri Amiri B, Radkhah H, Taslimi R, Shahbazi Dastjerdi Z, Khadembashiri MM, Gholizadeh Mesgarha M, Rahimipour Anaraki S. Thrombotic thrombocytopenic purpura following ChAdOx1 nCov-19 vaccination: A case report. IDCases. 2023, 32:e01795. 10.1016\/j.idcr.2023.e01795","journal-title":"IDCases"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10071012","article-title":"Acquired thrombotic thrombocytopenic purpura following inactivated COVID-19 vaccines: two case reports and a short literature review","volume":"10","author":"Ben Saida I","year":"2022","unstructured":"Ben Saida I, Maatouk I, Toumi R, Bouslama E, Ben Ismail H, Ben Salem C, Boussarsar M. Acquired thrombotic thrombocytopenic purpura following inactivated COVID-19 vaccines: two case reports and a short literature review. Vaccines (Basel). 2022, 10:10.3390\/vaccines10071012","journal-title":"Vaccines (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2022.04.020","article-title":"Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: a systematic review of reported cases","volume":"214","author":"Saluja P","year":"2022","unstructured":"Saluja P, Gautam N, Yadala S, Venkata AN. Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: a systematic review of reported cases. Thromb Res. 2022, 214:115-21. 10.1016\/j.thromres.2022.04.020","journal-title":"Thromb Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28592","article-title":"Thrombotic thrombocytopenic purpura after Ad6.COV2.S vaccination","volume":"14","author":"Ramanan S","year":"2022","unstructured":"Ramanan S, Singh H, Menon P, Patel PM, Parmar V, Malik D. Thrombotic thrombocytopenic purpura after Ad6.COV2.S vaccination. Cureus. 2022, 14:e28592. 10.7759\/cureus.28592","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.530","article-title":"Clinical and laboratory diagnosis of TTP: an integrated approach","volume":"2018","author":"Chiasakul T","year":"2018","unstructured":"Chiasakul T, Cuker A. Clinical and laboratory diagnosis of TTP: an integrated approach. Hematology Am Soc Hematol Educ Program. 2018, 2018:530-8. 10.1182\/asheducation-2018.1.530","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16619","article-title":"Thrombotic thrombocytopenic purpura presentation in an elderly gentleman following COVID vaccine circumstances","volume":"13","author":"Chamarti K","year":"2021","unstructured":"Chamarti K, Dar K, Reddy A, Gundlapalli A, Mourning D, Bajaj K. Thrombotic thrombocytopenic purpura presentation in an elderly gentleman following COVID vaccine circumstances. Cureus. 2021, 13:e16619. 10.7759\/cureus.16619","journal-title":"Cureus"},{"key":"ref10","article-title":"Thrombotic thrombocytopenic purpura","volume":"111","author":"Atrash S","year":"2015","unstructured":"Atrash S, Sajjad H, Jeanette R, Konstantinos A. Thrombotic thrombocytopenic purpura. J Ark Med Soc. 2015, 111:187-9.","journal-title":"J Ark Med Soc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-022-01466-y","article-title":"Thrombotic thrombocytopenic purpura after vaccination for COVID-19: lesson for the clinical nephrologist","volume":"36","author":"\u00d6zcan F","year":"2023","unstructured":"\u00d6zcan F, Brinkhoff A, Kiziler F, Bramlage P, Hollenbeck M. Thrombotic thrombocytopenic purpura after vaccination for COVID-19: lesson for the clinical nephrologist. J Nephrol. 2023, 36:647-9. 10.1007\/s40620-022-01466-y","journal-title":"J Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007599","article-title":"Real-world experience with caplacizumab in the management of acute TTP","volume":"137","author":"Dutt T","year":"2021","unstructured":"Dutt T, Shaw RJ, Stubbs M, et al.. Real-world experience with caplacizumab in the management of acute TTP. Blood. 2021, 137:1731-40. 10.1182\/blood.2020007599","journal-title":"Blood"},{"key":"ref13","unstructured":"Pfizer-BioNTech COVID-19 Vaccine\r\nPfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) Authorized For Individuals 6 Months through 11 Years of Age. (2023). Accessed. October 10, 2023: https:\/\/www.fda.gov\/vaccines-blood-biologics\/coronavirus-covid-19-cber-regulated-biologics\/pfizer-biontech-covid-19-v...."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi N","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018, 17:261-79. 10.1038\/nrd.2017.243","journal-title":"Nat Rev Drug Discov"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279535","article-title":"Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine","volume":"107","author":"Giuffrida G","year":"2022","unstructured":"Giuffrida G, Condorelli A, Di Giorgio MA, Markovic U, Sciortino R, Nicolosi D, Di Raimondo F. Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine. Haematologica. 2022, 107:1008-10. 10.3324\/haematol.2021.279535","journal-title":"Haematologica"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6364408","article-title":"High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus","volume":"8","author":"Niewold TB","year":"2007","unstructured":"Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun. 2007, 8:492-502. 10.1038\/sj.gene.6364408","journal-title":"Genes Immun"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117614","article-title":"Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura","volume":"10","author":"Edgar CE","year":"2015","unstructured":"Edgar CE, Terrell DR, Vesely SK, et al.. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura. PLoS One. 2015, 10:e0117614. 10.1371\/journal.pone.0117614","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017696","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"141","author":"Cines DB","year":"2023","unstructured":"Cines DB, Greinacher A. Vaccine-induced immune thrombotic thrombocytopenia. Blood. 2023, 141:1659-65. 10.1182\/blood.2022017696","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/194148-thrombotic-thrombocytopenic-purpura-following-pfizer-biontech-covid-19-vaccination-in-a-patient-with-multiple-myeloma-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:36Z","timestamp":1707509436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/194148-thrombotic-thrombocytopenic-purpura-following-pfizer-biontech-covid-19-vaccination-in-a-patient-with-multiple-myeloma-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.46784","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,10]]}}}